Congresswoman Susan W. Brooks

Representing the 5th District of Indiana
Twitter icon
Facebook icon
YouTube icon
Instagram icon

Strengthening Biodefense

More on Strengthening Biodefense

Sep 18, 2020 In The News

On Friday September 18, Axios' Margaret Talev hosted a conversation on the 2020 election, exploring the Trump and Biden administrations' positions on everything from health care to economics to the coronavirus response, featuring Rep. Ro Khanna and Rep. Susan Brooks.

Sep 18, 2020 In The News

Insufficient stockpiles and a lack of personal protective equipment during the COVID-19 pandemic should serve as a warning for America on future preparedness, Rep. Susan Brooks (R-Ind.) said at an Axios virtual event on Friday.

What they're saying: "Congress had been beefing up for years — the appropriations for preparedness — it certainly was not enough, and we recognize that," Brooks said.

May 5, 2020 In The News

U.S. Rep. Susan Brooks (R-IN) on May 1 introduced bipartisan legislation that would fund exploratory strategies designed to increase domestic drug manufacturing and diversify the nation’s drug supply chain.

“This bipartisan legislation will take rapid steps to ensure the United States has better visibility into our own pharmaceutical supply chain,” Rep. Brooks said on Friday.

May 5, 2020 In The News

U.S. Reps. Susan Brooks (R-IN) and Anna Eshoo (D-CA) introduced legislation that would establish a committee of experts to analyze the impact of U.S. dependence on the foreign manufacturing of lifesaving drugs.

The Prescription for American Drug Independence Act would require the National Academies of Sciences, Engineering, and Medicine to convene this expert committee. The committee would make recommendations to Congress within 90 days to ensure the U.S. has a diverse drug supply chain to adequately protect the country from natural or hostile occurrences.

May 1, 2020 News Releases

WASHINGTON, DC – Today, Congresswomen Susan W. Brooks (IN-05) and Anna G. Eshoo (CA-18) introduced the Prescription for American Drug Independence Act. The legislation requires the National Academies of Sciences, Engineering, and Medicine to convene a committee of experts to analyze the impact of U.S. dependence on the manufacturing of lifesaving drugs and make recommendations to Congress within 90 days to ensure the U.S. has a diverse drug supply chain to adequately protect our country from natural or hostile occurrences.

Apr 21, 2020 In The News

During the current pandemic, many American nonprofits and businesses stepped up to donate medical equipment to the Strategic National Stockpile but had no direct way to do it, U.S. Rep. Susan Brooks (R-IN) said recently.

In response, the congresswoman on April 17 sponsored the bipartisan Stockpiling for America’s Future Endeavors (SAFE) Act, H.R. 6516, with lead cosponsor U.S. Rep. Kim Schrier (D-WA) to bolster direct donations to the Strategic National Stockpile.

Apr 17, 2020 News Releases

WASHINGTON, DC – Today Congresswomen Susan W. Brooks (R-IN05) and Kim Schrier, M.D. (D-WA08) introduced H.R. 6516, the Stockpiling for America’s Future Endeavors (SAFE) Act to improve our nation’s Strategic National Stockpile (SNS).

Apr 17, 2020 News Releases
WASHINGTON, DC – Today Congresswomen Susan W. Brooks (R-IN05) and Anna Eshoo (D-CA18) introduced H.R. 6517, the Stockpile Inventory Modernization (SIM) Act of 2020 to allow our Strategic National Stockpile to better serve Americans.
 
Apr 17, 2020 In The News

Congresswoman Susan W. Brooks (R-IN05) introduced two bills Friday regarding the nation's Strategic National Stockpile (SNS).

Brooks and Rep. Kim Schrier (D-WA08) introduced H.R. 6517, the Stockpiling for America’s Future Endeavors (SAFE) Act to improve the SNS.

Apr 17, 2020 In The News

Today Congresswomen Susan W. Brooks (R-IN05) and Kim Schrier, M.D. (D-WA08) introduced H.R. 6517, the Stockpiling for America’s Future Endeavors (SAFE) Act to improve the Strategic National Stockpile (SNS).

Under current law, the SNS cannot accept donation of equipment or medical countermeasures without going through a complex transaction with the Department of Health and Human Service (HHS) and General Services Administration (GSA). In practice, very few of these donations are accepted because of this complexity.